Van Harten

Nov 22, 2024 | bmccancer.biomedcentral.com | Van Schaik |Van Harten |Lucas Frederik |Ellen Gurumay

In total, 19 stakeholders were interviewed from seven different regions in the Netherlands. The stakeholder group ‘molecular specialists’ consisted of three pathologists and four respondents who were either a molecular biologist in pathology or a laboratory specialist in clinical genetics (Table 2). The ‘medical specialists’ group consisted of four medical oncologists, one pulmonologist and two clinical geneticists.

Aug 11, 2023 | arxiv.org | Van Harten

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.